Women more likely to take part in clinical trials they discover through peers

March 10, 2017

Women are often underrepresented in HIV clinical trials, making it difficult to decipher the relevance of findings and whether they are applicable to all.

Coinciding with National Women and Girls HIV/AIDS Awareness Day, new data published today in the Taylor & Francis journal HIV Clinical Trials uncovers how an evidence-based campaign, Follow YOUR Heart, is empowering older women with HIV to participate in a large-scale clinical trial aimed at preventing cardiovascular disease, the REPRIEVE trial.

Massachusetts General Hospital and Harvard Medical School researchers Dr Sara Looby and Dr. Markella Zanni uncovered women's preferred methods for learning about a trial were peer-to-peer communication (52% of those questioned), provider communication (46%) and video-based communication (39%). Women were most likely to take part to gain information (63%) and to help others (47%).

Dr. Looby and Dr. Zanni commented: "Feedback from our community sample of women offered valuable perspectives on methods to help educate and engage women with HIV on research participation, making our Follow YOUR Heart campaign truly patient-centered."

Explore further: Better health for women involved in clinical trials

More information: Markella V. Zanni et al. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial, HIV Clinical Trials (2017). DOI: 10.1080/15284336.2017.1297551

Related Stories

Better health for women involved in clinical trials

February 14, 2017
Women who participate in obstetric and gynaecology clinical trials experience improved health outcomes compared to those who are not involved in trials, according to research by Queen Mary University of London (QMUL). This ...

Most women feel PCPs are involved in breast cancer care

October 10, 2016
(HealthDay)—Most women newly diagnosed with breast cancer perceive high primary care provider (PCP) quality, and report that their PCPs have high engagement and communication, according to research published online Oct. ...

Regrets? Opting out of clinical trials may prompt more than a few

May 20, 2015
Women who choose not to participate in a clinical trial may be significantly more likely to later regret that decision than women who choose to participate in the study, according to a team of Penn State researchers.

Results from the PLATINUM DIVERSITY study presented

November 1, 2016
A dedicated stent study conducted exclusively in women and minority patients evaluated clinical outcomes within the era of contemporary PCI, comparing these results to a parallel cohort of white male patients. Although there ...

Major clinical trial led to steep declines in use of an ineffective breast cancer treatment

July 7, 2016
Many common medical treatments have never been tested in a clinical trial. A new study published in the July issue of Health Affairs highlights how evidence from trials of untested but widely used treatments can change medical ...

Type 2 diabetes drug trials unnecessarily exclude women

May 5, 2016
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn ...

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.